Patents by Inventor Hadley Mouhsine

Hadley Mouhsine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230416239
    Abstract: The present invention relates to a compound of the following formula (I): in particular for use use in the diagnostic, prevention or treatment of a cytokine-mediated disease in an individual.
    Type: Application
    Filed: November 12, 2021
    Publication date: December 28, 2023
    Inventors: Hadley MOUHSINE, Aïda MASCRET, Marc PORT, Jean-François ZAGURY, Matthieu MONTES, Maite SYLLA, Christophe RICCO, Damien CABRERA, Mohamed BENCHEKROUN
  • Patent number: 8975399
    Abstract: A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.
    Type: Grant
    Filed: July 19, 2011
    Date of Patent: March 10, 2015
    Inventors: Jean-Francois Zagury, Matthieu Montes, Hadley Mouhsine, Helene Guillemain
  • Publication number: 20130123266
    Abstract: A benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids, for its use in a method for treating a pathology linked to an excessive effect of TNF-alpha and for its use in a method for treating the human or animal body as a direct inhibitor of TNF-alpha.
    Type: Application
    Filed: July 19, 2011
    Publication date: May 16, 2013
    Applicant: VAX-CONSULTING
    Inventors: Jean-François Zagury, Matthieu Montes, Hadley Mouhsine, Hélène Guillemain